BECAUSE IT COULD MEAN MORE PEOPLE WILL GET SICK. CONCERNS ABOUT A POSSIBLE SUPER FLU SURGE. A NEW VARIANT SWEEPING THE COUNTRY. IT’S NOT THAT THAT AN EVOLVED STRAIN OR A DIFFERENT STRAIN IS GOING TO ...

The Food and Drug Administration last week refused to review Moderna’s application for its messenger RNA flu vaccine, in a move that the Cambridge biotech said came as a surprise. In a “Refusal to ...

From how to stay well to reducing symptoms if you do get sick, the more you know about the flu the better off you’ll be in ...

The ruling could energize Kennedy's supporters to fight back, or provide cover for the administration to leave vaccines ...

This season's flu vaccine didn't work as well as usual, officials say A new virus strain did not match the shot well Scientists are already planning for next winter's vaccines MONDAY, March 16, 2026 ...

Moderna seeks to return to growth Its share price has lost 90% from pandemic peaks Anti-vaccine health secretary has disrupted US vaccine policy Feb 27 (Reuters) - Europe's medicines regulator ...

For the past week, about 50 flu scientists from around the world were crammed into a conference room at a Hilton hotel in Istanbul, Turkey. Their goal was to design a flu shot that will confer the ...

Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will ...

Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...

The Food and Drug Administration has reversed its decision not to review a new flu vaccine from Moderna, the pharmaceutical company said Wednesday. Last week, the FDA sent a missive to Moderna ...

The FDA has accepted Moderna’s revised influenza vaccine filing days after controversially refusing to review the original submission, putting the biotech on track to win approval in time for the 2026 ...